Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children

Name: Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
Published: 2021
License: Public Domain

BioNTech SE · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

mrna-vaccine sars-cov-2

sars-cov-2 infection, covid-19, covid-19, coronavirus vaccine, sars-cov-2, rna vaccine, mrna vaccine, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children

Related documents